MPIA
NVO

Mountain Pacific Investment Advisers’s Novo Nordisk NVO Stock Holding History

Mountain Pacific Investment Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,216
Closed -$320K – 121
2019
Q1 		$320K Buy
+12,216
New +$300K 0.03% 103

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mountain Pacific Investment Advisers's NVO Position: Q2 2019 in Review

Mountain Pacific Investment Advisers sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 12,216 shares — an estimated $320K sold.

Mountain Pacific Investment Advisers first reported a position in NVO in Q1 2019 and held it in 1 quarter. The position peaked at $320K in Q1 2019. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Mountain Pacific Investment Advisers reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
  • Mountain Pacific Investment Advisers sold 12,216 Novo Nordisk shares in Q2 2019, an estimated $320K.
  • Mountain Pacific Investment Advisers first reported a position in Novo Nordisk in Q1 2019 and held it in 1 quarter.
  • Mountain Pacific Investment Advisers's Novo Nordisk position peaked at $320K in Q1 2019.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Mountain Pacific Investment Advisers's 13F filing for Q2 2019, filed 23 Jul 2019.